“…Its importance is reflected in the immense economic value of pharmaceuticals including Valsartan [70,71] and Telmisartan [72,73], and agrochemicals such as Boscalid [74]. As alternatives to the homogeneous Pd-phosphine catalysts, Pd on carbon [75,76], on silica or polymer supports [77][78][79], and on mesoporous materials can be used [80,81]. Silica-supported Pd catalysts useful for Suzuki crosscoupling reactions can be prepared in various ways providing different structures and activity.…”
“…Its importance is reflected in the immense economic value of pharmaceuticals including Valsartan [70,71] and Telmisartan [72,73], and agrochemicals such as Boscalid [74]. As alternatives to the homogeneous Pd-phosphine catalysts, Pd on carbon [75,76], on silica or polymer supports [77][78][79], and on mesoporous materials can be used [80,81]. Silica-supported Pd catalysts useful for Suzuki crosscoupling reactions can be prepared in various ways providing different structures and activity.…”
“…Although, Diflunisal has been prepared in one step by Suzuki coupling, excellent yield was obtained only by using a phosphine based catalyst, glovebox and degassed water (Scheme 5) [20]. Also, Felbinac has been prepared by Suzuki coupling using either phenylboronic acid [25,26] or tetraphenylborate [5,27] as reactant (Scheme 6). Suzuki coupling with free hydroxyl or carboxylic acid functionalities present in the aromatic halide have been reported but, aryltrifluoroborates, strong bases (KO t Bu, LiOH, KF), microwave or phosphine based palladium catalysts have been utilized [28][29][30][31][32][33].…”
Section: Catalytic Preparation Of Diflunisalmentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.